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ABSTRACT
IN VITRO ASSESSMENT OF THE TOXICITY OF COCAINE
AND ITS METABOLITES IN THE HUMAN UMBILICAL ARTERY
by
Tessa L. Long
An in vitro model was used to assess the effect o f cocaine and its metabolites on
the umbilical artery. Objectives were to pharmacologically confirm the presence
o f adrenergic innervation using tyramine, evaluate the ability o f cocaine,
benzoylecgonine, norcocaine and cocaethylene to potentiate vasoconstriction by
serotonin and norepinephrine, examine the ability o f ketanserin to block the
enhanced vasoconstriction produced by cocaine, and determine displacement of
3H-ketanserin by serotonin, norepinephrine, tyramine and mianserin.
The vasoconstrictive effect of tyramine (100 |iM) was enhanced in the presence of
cocaine by 257%. Vasoconstrictive effects o f serotonin and norepinephrine were
significantly enhanced by cocaine by 28%, and 64% respectively; producing
significant increases in the cumulative response. Norcocaine significantly
augmented the maximum response to norepinephrine by 54%. Benzoylecgonine
significantly decreased the maximum response to serotonin by 36% as well as the
cumulative response.
Ketanserin (0.03 jiM) completely attenuated the vasoconstricitive potentiation of
serotonin and norepinephrine by cocaine; shifting the EC50 for serotonin to the
right 10-fold in the presence o f ketanserin and cocaine. Ketanserin shifted the
EC 15 for norepinephrine with cocaine to the right 205-fold. Maximum response
to norepinephrine with cocaine was depressed 54% by ketanserin.
Serotonin, tyramine, and mianserin were able to displace 3H-ketanserin (3 nM)
from the membrane fraction o f the human umbilical artery. This indicates
serotonin2 receptor involvement in vasoconstrictive responses to serotonin and
tyramine. Norepinephrine did not displace 3H-ketanserin in the membrane fraction
o f the umbilical artery.

iii
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These data suggest that enhanced vasoconstriction o f norepinephrine and serotonin
by cocaine and potentiation of the maximum response to norepinephrine by
norcocaine in the human umbilical artery may be important components of
perinatal cocaine toxicity. Ketanserin was able to suppress the umbilical artery
constriction produced by cocaine, demonstrating its antidotal potential. The
potentiation o f the tyramine response by cocaine and the displacement o f 3Hketanserin by tyramine indicate that tyramine may be producing its
vasoconstrictive effect through serotonin2 receptors in the human umbilical artery.
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CHAPTER 1
INTRODUCTION

Survey o f Deleterious Perinatal Cocaine Effects
Human epidemiological data has consistently implicated cocaine use during
pregnancy with various perinatal and postnatal complications. Infants bom to
cocaine abusing mothers suffer many complications including genito-urinary
anomalies (Chasnoff et al. 1988), cerebral infarct (Chasnoff et al. 1986), and
ischemic infarct o f the bowel (Telsey et al. 1988) as well as various other
anomalies. A study conducted by MacGregor et al. (1987) surveyed the outcome
of 70 newborns, those infants exposed to cocaine in utero presented with
significantly lower birth weights as well as increased incidence o f prematurity,
preterm delivery, and small for gestational age newborns. Perinatal cocaine abuse
often compromises the pregnancy itself with increased incidence o f placental
abruption (Acker et al. 1983; Chasnoff et al. 1985; Oro and Dixon 1987), stillbirths
(Bingol et al. 1987), spontaneous abortion, and preterm labor (Chasnoff et al.
1985; Chasnoff et al. 1987; MacGregor et al. 1987; Collins et al. 1989). These
effects seem to be predominantly related to the vasoconstrictive and hypertensive
actions of cocaine (Plessinger and Woods 1991).

1
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2
Animal models have provided useful information concerning cocaine
mechanisms which contribute to deleterious perinatal and postnatal effects.
Placental vasoconstriction as a consequence o f cocaine administration has been
observed in a mouse model by Mahalik et al. (1984) and by Malek et al. (1995) in
isolated term human placenta. Several studies have confirmed the ability o f
cocaine to reduce uterine blood flow. Among the first to conduct such studies was
Mahalik et al. (1984), who observed this decrease in blood flow in response to
norepinephrine mediated vasoconstriction in the pregnant ewe. They
demonstrated this concept experimentally by incorporating tropacocaine, an agent
similar to cocaine which does not inhibit the reuptake o f norepinephrine into the
nerve terminal. In cocaine-exposed animals, there was a decrease in the amount of
radio labeled sodium transferred to the embryos. However, in the tropacocaineexposed animals the transfer o f the isotope was not reduced significantly. In
response to intravenous cocaine administered to the uterine vasculature o f the
pregnant ewe (Woods et al. 1987; Moore et al. 1986), and to the pregnant
nonhuman primate (Morgan et al. 1991), a dose-dependent reduction of uterine
blood flow was observed. This results in increased blood pressure and restricts the
delivery o f essential nutrients and oxygen to the fetus.
Moreover, it has been established that cocaine readily crosses the placenta,
producing increases in fetal heart rate and blood pressure in the pregnant ewe
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3
(Woods et al. 1987). Numerous studies conducted in animal models indicate that
cocaine and its metabolites are rapidly transferred across the placenta to the fetal
compartment (Moore et al. 1986; Woods et al. 1989). Schenker et al. (1993)
observed that cocaine and its metabolites are transferred across the isolated human
placenta almost as rapidly as antipyrine, a substance which is used as a marker for
placenta flow. These observations suggest that cocaine may exert its detrimental
effects not only by producing fetal hypoxemia through reduction of blood flow to
the uterine and placental vasculature, but also by crossing the placenta to have
direct effects on the fetus.
Several o f the perinatal and postnatal cocaine effects observed in animal
models have been linked to similar effects observed in human epidemiological
data. These effects are produced by vasoconstriction and include placental
abruption, placental constriction, reduced uterine blood flow and decreased
viability o f the fetus. Animal model correlations provide some insight concerning
the perinatal toxic potential of cocaine, however, the full impact of continuous
cocaine abuse throughout the pregnancy remains to be elucidated.

Survey o f Cocaine Effect on the Human and Ovine Umbilical Artery
The umbilical vasculature is an important component o f the maternal-fetal
unit which has not been carefully assessed in terms o f its contribution to the
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4
vasoconstrictive effects associated with cocaine abuse during pregnancy. Dyer
(1970) produced a dose-dependent potentiation of serotonin vasoconstriction by
cocaine in isolated strip preparations o f ovine umbilical arteries, but saw no such
potentiation o f norepinephrine responses. In the isolated guinea pig umbilical
artery, Nair and Dyer (1974) found that cocaine potentiated the contractions
produced by serotonin and norepinephrine, shifting the dose-response curves to the
left three-fold. Hoskins et al. (1991) performed umbilical artery Doppler flow
velocimetry studies on 314 women who had a history of cocaine abuse, and
placental abruption or preterm labor and compared these women with controls
presenting with placental abruption or preterm labor but did not use cocaine. They
reported cocaine abuse associated with placental abruption, preterm birth, and low
birth weight was correlated with increased systolic/diastolic ratios in human
umbilical artery blood flow in some women. Recently, Zhang and Hu (1998)
demonstrated that cocaine potentiates isolated ovine umbilical artery contractions
produced by serotonin in the endothelium-intact preparation. These studies
provide evidence that cocaine may directly potentiate constriction o f the umbilical
artery.
Bodelsson and Stjemquist (1995) did not observe a potentiation of
norepinephrine by cocaine in the isolated human umbilical artery. This suggests
that serotonin may be more important to umbilical artery vasoconstriction as
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a possible contributing factor in the morbidity and mortality associated with
cocaine exposure to the developing fetus.

Pharmacological Mechanism o f Cocaine
The adverse perinatal and neonatal outcomes associated with cocaine abuse
during pregnancy have generally been attributed to the vasoconstrictive effects of
cocaine and its metabolites. This vascular effect is thought to be related to the
ability o f cocaine and its metabolites to block the reuptake o f norepinephrine at the
presynaptic nerve terminal, inhibiting the primary means of inactivation for this
neurotransmitter (Furchgott et al. 1963).
Several very elegant studies have contributed to what is now known about
the pharmacological actions of cocaine. A study conducted by Lockett and Eakins
(1960) revealed that cocaine was able to abolish the pressor response to tyramine
in cats. Since tyramine is an indirect acting sympathomimetic which produces its
effects by displacing norepinephrine from presynaptic nerve terminals, the results
o f this study indicate that cocaine exerts its effect by altering the transport of
catecholamines into the nerve terminal. This mechanism was first described by
Kirpekar et al. (1962), who proposed that cocaine blocks a specific "transfer site".
Furchgott et al. (1963), Trendelenburg (1965), Johnson and Kahn (1966), and
Barnett et al. (1968) have provided definitive evidence that cocaine blocks the
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Figure I. Diagrammatic representation of the pharmacological mechanism o f cocaine.

synaptic reuptake o f catecholamines, increasing norepinephrine levels and postsynaptic stimulation o f adrenergic receptors (Bayorh et al. 1983) (Figure 1).
Systemic pressor effects o f cocaine administration are produced by
increased plasma levels o f norepinephrine which increase systemic vascular
resistance. Thus, many o f the toxic effects associated with perinatal cocaine abuse
may be due to its hemodynamic alterations. If the response o f the umbilical
vasculature is similar to that o f other tissues, vasoconstriction o f this tissue could
contribute to the reduced perfusion o f the developing fetus resulting in many o f the
previously described perinatal complications.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

7
Survey o f the Vascular Effects o f Cocaine Metabolites
Cocaine is extensively metabolized in the plasma and liver, its metabolites
are cleared from the plasma more slowly than cocaine itself (Jatlow 1987). Several
o f the resulting metabolites exhibit pharmacological activity similar to that of
cocaine. Benzoylecgonine is the major metabolite (80%) o f cocaine formed after
hydrolysis by nonspecific plasma and liver esterases. Benzoylecgonine is reported
to possess pharmacological activity to produce vasoconstriction o f cat cerebral
arteries (Madden and Powers 1990). Cocaethylene (Jatlow et al. 1991) is a toxic
metabolite o f cocaine formed by the liver when cocaine and ethanol are used
concomitantly by benzoylecgonine carboxylesterase (Boyer and Petersen 1991),
the amount of cocaethylene formation is dependent on plasma concentration of
ethanol. The presence o f ethanol shifts metabolism of cocaine from
benzoylecgonine to cocaethylene and increases the formation o f norcocaine (Farre
et al. 1993). Cocaethylene is purported to be more cardiotoxic than cocaine
(Randall 1992) and exhibits a lower LD50 in mice (Hearn et al. 1991). Norcocaine
is formed by N-demethylase in human liver and accounts for 20% o f cocaine
metabolism (Stuart et al. 1979). Norcocaine is more efficacious than cocaine itself
at inhibiting synaptic reuptake o f norepinephrine (Hawks et al. 1975). In one
experiment involving porcine fetal cerebral arteries, cocaethylene was able to
produce vasoconstriction in these vessels more efficaciously than cocaine. In the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

8
same study, norcocaine was shown to constrict these vessels as efficaciously as
cocaine itself (Kurth et al. 1993). Similar effects were described in fetal lambs,
Covert et al. (1994) reported increased cerebral vascular resistance in response to
cocaethylene and benzoylecgonine administration.
Dining pregnancy, the toxicity of cocaine and its metabolites is greater due
to decreased activity of cytochrome P450enzymes and increased plasma levels of
progesterone (Neale and Parks 1973). Progesterone increases enzymatic
demethylations thereby increasing plasma concentrations of longer-lived toxic
cocaine metabolites and by increasing vascular reactivity to alpha-adrenergic
receptor agonists. Pregnancy itself enhances cocaine sensitivity by increasing the
formation o f norcocaine and cocaethylene while decreasing norcocaine
metabolism. In one study, the cardiovascular toxicity to cocaine was shown to be
increased in the presence of progesterone in nonpregnant ewes (Plessinger and
Woods et al. 1990).

Question o f Innervation in the Human Umbilical Cord
The subject of innervation in the umbilical vasculature has been a topic of
controversy for several decades. Even as recently as 1990 the conflict continued;
it was demonstrated that adrenergic and cholinergic nerve fibers are present in
umbilical arteries at the fetal end o f the human umbilical cord using histochemical
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techniques (Kawano and Mori 1990). In the same year another study reported no
evidence o f innervation using immunohistological and histochemical techniques
(Fox and Khong 1990).
Functional in vitro studies have provided some information that supports
the existence innervation o f human umbilical arteries. Gulati and Kelkar (1970)
found that cocaine potentiates the responses o f norepinephrine and serotonin in a
human whole cord perfusion study. They also found that tyramine produced
vasoconstriction o f the artery and this response was potentiated by cocaine. These
findings suggest that the human umbilical cord is innervated and that cocaine and
its metabolites potentiate responses to serotonin and norepinephrine thereby
contributing to toxic vasoconstrictive situations produced with perinatal cocaine
abuse.

Question of Receptor Types Present in Human Umbilical Arteries
Norepinephrine produces contractions o f less than half the KC1 maximum
in isolated umbilical arteries even at high concentrations (Bodelsson and
Stjemquist 1995). This is a very unusual response for arterial tissue which is
normally characterized as primarily alpha-adrenoceptor mediated. Bodelsson and
Stjemquist (1995) were able to produce contractions o f isolated human umbilical
artery rings with oxymetazoline, an alpha2agonist, however the maximum
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response was five times higher than that o f norepinephrine itself suggesting that
oxymetazoline produced its effects through another receptor. The authors
concluded that oxymetazoline was probably acting through serotonin receptors
since methysergide, a nonspecific serotonin antagonist, produced a parallel shift in
the concentration-effect curve for oxymetazoline. In the same study, the authors
noted that prazosin (alpha, antagonist) produced concentration-dependent
reductions in the concentration-effect curves to norepinephrine, but not a parallel
shift o f the response. The authors concluded that norepinephrine produced its
effects through both alpha, and alpha2 receptors. Adding to the confusion, Tuncer
et al. (1985) were not able to produce contractions o f this tissue at all with
clonidine, an alpha, agonist. These observations suggest that norepinephrine may
be producing its effects through another receptor type, possibly serotonin
receptors.
Serotonin is a very potent vasoconstrictor o f human umbilical arteries
(Gokhale et al. 1966; Altura et al. 1972; Tuncer et al. 1985; McGrath et al. 1988;
Yoshikwa and Chiba 1991) and this response is antagonized by the serotonin2
receptor antagonists ketanserin and mianserin (Tuncer et al. 1985). The pA2
values (slope o f the regression of KDvalues obtained for an agonist over several
concentrations o f antagonist) reported in Tuncer’s study in the human umbilical
artery for ketanserin and mianserin were 7.89 and 8.06. These values were
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significantly lower than those reported for other tissues; including rat jugular vein
(Cohen et al. 1983) and rat uterus (Ichida et al. 1983), where observed mianserin
pA2values were 9.30 and 9.70, and in the same tissues as well as calf coronary
arteries (Kaumann 1983) and rat tail arteries (Hicks and Langer 1983) ketanserin
pA2 values ranged from 9.10-9.80. Based on these numbers Tuncer et al. (1985)
concluded that serotonin induced contractions in the isolated human umbilical
artery were mediated by neither serotonin, nor serotonin2 receptors.
These contributions to the literature concerning the receptor types
responsible for norepinephrine and serotonin mediated contractions of isolated
human umbilical arteries leave many unanswered questions about the serotonin
and alpha, adrenoceptor population present in this tissue. This information is vital
to the understanding o f how cocaine might be exerting its effects and what
compounds might be useful in antagonizing cocaine potentiation of norepinephrine
and serotonin vasoconstriction.

Role o f Ketanserin in the Treatment o f Hypertension
Serotonin seems to play an important role in the sequelae of preeclampsiaeclampsia. Several studies have noted the benefit o f ketanserin therapy in the
treatment o f this perinatal complication (Ghisoni 1990; Rossouw et al. 1995; Steyn
and Odendaal 1997). Rossouw et al. (1995) found ketanserin to be a safer
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alternative to hydralazine therapy in late term hypertension and Steyn and
Odendaal (1997) found ketanserin to be a beneficial addition to low dose aspirin
therapy among women with mild to moderate midtrimester hypertension.
Ketanserin has also been found to be useful in other types o f hypertensive
situations (Van Neuten et al.1981; DeCree et al. 1981; Symoens and Janssen
1986). Tuncer et al. (1985) did notice that ketanserin produced effects on isolated
human umbilical artery strips, significantly shifting concentration-effect curves to
serotonin. This information opens the possibility o f a role for ketanserin in
perinatal hypertensive situations produced by cocaine abuse.

Statement o f the Problem
Human epidemiological data, whole animal studies, and isolated tissue
studies have confirmed that cocaine produces vasoconstrictive situations which
contribute to the well documented deleterious consequences o f perinatal cocaine
abuse. The contribution o f placental and uterine vasoconstriction has been
established in animal models and in isolated perfused placentas. The constriction
o f umbilical vessels in this situation has not been studied as carefully. Research to
date indicates that cocaine may produce potentiation of serotonin and/or
norepinephrine mediated vasoconstriction in the human umbilical artery, further
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exacerbating the reduced perfusion o f the fetus produced by the constriction of the
uterine artery and the placental vasculature.
Requisite to a situation whereby cocaine produces a vasoconstrictive or
hypertensive situation in the umbilical artery via its conventionally described
mechanism is the presence o f nerve terminals in the smooth muscle o f the
vasculature. There is histological (Kawano and Mori 1990) and functional (Gulati
and Kelkar 1970) data to indicate that human umbilical arteries are innervated.
However, this tissue is usually described as non-innervated due to previous
histological studies which were unable to detect nerve endings in the human
umbilical cord. Central to understanding the mechanisms by which cocaine might
produce vasoconstriction in this tissue is determination of innervation.
The ability o f cocaine to potentiate norepinephrine induced
vasoconstriction in the human umbilical artery is disputed by Bodelsson and
Stjemquist (1995) and supported by Gulati and Kelkar (1970). Gulati and Kelkar
(1970) found that cocaine also potentiated the vascular response o f serotonin in the
whole perfused human umbilical cord. Zhang and Hu (1998) noted the same effect
in isolated ovine umbilical artery rings. This effect as well as the impact of
pharmacologically active circulating metabolites o f cocaine requires further
elucidation.
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Several experiments have failed to reveal definitive information about the
receptor types responsible for the vasoactive effects o f norepinephrine and
serotonin in the umbilical artery. Bodelsson and Stjemquist (1995) concluded that
alpha, and alpha2adrenoceptors are responsible for norepinephrine induced
contractions of isolated human umbilical artery rings even though they were
unable to produce parallel shifts in concentration-effect curves with alpha
antagonists and Tuncer et al. (1985) failed to produce contractions o f human
umbilical arterial strips with alpha2 agonist clonidine. Tuncer et al. (1985) were
also unable to describe the receptor types responsible for serotonin induced
contractions, though ketanserin and mianserin did produce parallel shifts in
concentration-effect curves. Receptor-binding studies would help to further
establish receptor types present in this tissue.
Ketanserin may provide a useful antidote for the acute toxicity o f perinatal
cocaine abuse. This agent has proven useful in clinical trials for the treatment of
pregnancy-induced hypertension, preeclampsia-eclampsia (Rossouw et al. 1995).
The potency o f serotonin in the umbilical artery indicates that potentiation of
serotonin responses could be very devastating to the developing fetus exposed to
cocaine. Functional studies in the human umbilical artery by Tuncer et al. (1985)
indicate that ketanserin may be useful in the treatment of a hypertensive situation
where fetal hypoxia and placental abruption are impending.
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Aims o f the Study
The present study was designed to assess the toxicity o f cocaine in vitro in
the isolated human umbilical artery. Experiments were designed to provide
information about several functional aspects o f the umbilical artery itself and the
impact of cocaine and its pharmacologically active metabolites in this system.
The experimental goals are as follows:
1.

To determine the effect o f tyramine on the isolated human umbilical artery.
These experiments would provide information about the extent of
innervation in this tissue.

2.

To determine the ability o f cocaine and its pharmacologically active
metabolites, cocaethylene, norcocaine, and benzoylecgonine, to potentiate
the vasoconstrictive responses to norepinephrine and serotonin in isolated
human umbilical arteries.

3.

To determine the ability o f serotonin2antagonist ketanserin to attenuate the
augmentation o f serotonin and norepinephrine effects by cocaine in
umbilical arteries.

4.

To determine the effect o f methoxamine, an alpha, agonist, on umbilical
arteries. This will provide information concerning the receptor types
involved in the response to norepinephrine.
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5.

To determine if norepinephrine, serotonin, tyramine, and mianserin interact
with the serotonin2 receptors by displacement o f 3H-ketanserin in isolated
membrane fractions o f umbilical arteries.
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CHAPTER 2
MATERIALS AND METHODS

Subjects
The protocol for this study was approved by the East Tennessee State
University and the Johnson City Medical Center Institutional Review Boards.
Pregnant women under the care o f University Physicians Practice Group Obstetrics and Gynecology at Johnson City Medical Center were asked to
participate in this study. All subjects were informed o f their rights as a human
subject and signed an informed consent (see Appendix A and B for informed
consent and IRB approved protocol). Women with a history o f perinatal drug
abuse, hypertension, or pregnancy induced hypertension were excluded from the
study. Umbilical cord sections were taken from the fetal end o f the umbilical cord,
within 15 cm o f the fetus.

Contractile Studies of the Human Umbilical Artery

Tissue Preparation and Equilibration
Umbilical cords were collected from term vaginal or cesarean deliveries and
immediately placed in oxygenated, modified Krebs-Henseleit buffer (see
Appendix C for preparation scheme) o f the following composition (mM): NaCl

17
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(112.94), KC1 (4.75), CaCl2 (2.52), MgS04 (1.19), Dextrose (5.55), KH2P 0 4
(1.18), and NaHC03 (25.00), and stored until dissection at room temperature.
Tissues were prepared for experimentation within 2 hours o f collection. Sections
of artery were dissected from the cord and carefully cleared o f Wharton’s jelly
(under buffer) using fine forceps and a FISHER Stereoscope. Sections were cut
with fine surgical scissors while still under buffer to make 3mm rings of arteries.
The rings were placed in individual jacketed organ baths containing modified
Krebs-Henseleit buffer. The baths and the buffer were maintained at 37° C
throughout the experiments and the buffer was continuously aerated with a
mixture of 95% 02/5% C 02. Buffer in the organ baths was replaced every 20-30
min throughout the experiments with pre-warmed modified Krebs-Henseleit
buffer.

Measurement o f the Contractile Response
Umbilical artery rings were suspended horizontally in 8.2 ml organ baths by
two hooks which were placed through the lumen o f the vessel. The upper hook
was attached to Grass model FT03C force displacement transducers (Quincy, MA)
via surgical suture, and the bottom support was stabilized outside the bath with a
clamp. Isometric contractile responses were recorded by a Grass Model 7D
polygraph (Quincy, MA). Tissues were allowed to equilibrate for 90-120 minutes
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under 2gm tension (optimal resting tension as determined empirically) then
contracted every 30 min with 65mM KC1 (replacing Na+) in modified KrebsHenseleit buffer (see Appendix D for preparation scheme) until contractions were
stable to determine tissue viability and maximum standard response o f each tissue.
Experiments were performed to determine the length o f time tissues would
maintain stable contractions with 65 mM KC1. Receptor agonists were dissolved
in water and administered in 8.2 pi volumes with Eppendorf digital pipettes to
yield the appropriate molar concentrations. Cumulative concentration-effect
curves (van Rossum 1963) to agonists were constructed by the addition o f log or
0.5 log concentration increments to the bath to yield final concentrations as
indicated. A period of at least 2.5 min for measurement of maximum response was
allowed after addition o f each concentration. Tissues were washed at least twice
after a concentration-effect curve and allowed to return to basal tension before the
next concentration-effect curve was begun. Several concentration-effect curves
were constructed for each agonist over a period o f several hours to determine
increases and decreases in sensitivity to each agonist.

Assessment of Innervation
The innervation of the human umbilical artery was assessed using tyramine,
an indirect acting sympathomimetic which enters adrenergic nerve terminals and
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elicits a contractile response by causing the release o f endogenous norepinephrine.
Tissues were exposed to 10 pM and 100 (iM concentrations o f tyramine, then
washed with fresh buffer and allowed to relax. Once the tissues had relaxed to
baseline tension the rings were exposed to buffer containing 10 pM cocaine for 30
minutes then reexposed to each concentration o f tyramine. A 10 pM concentratio
o f cocaine was used to assure complete blockade o f the uptake-1 site.

Agonist Responses in the Presence and Absence of Cocaine
In order to assess the ability o f cocaine to enhance responses to endogenous
neurotransmitters concentration-effect curves were constructed for norepinephrine,
and serotonin in the presence or absence o f cocaine. Tissues were exposed to
cumulative concentrations o f either serotonin or norepinephrine (0.01 - 10 pM).
Tissue rings were then rinsed with fresh buffer and allowed to relax back to
baseline tension. Cocaine (10 pM) was added to the baths and after an
equilibration o f 30 min, the concentration-effect curves for serotonin or
norepinephrine were reconstructed in the presence o f cocaine. The presence or
absence o f cocaine was randomized and each tissue served as its own control.

Effect o f Benzolecgonine. Norcocaine. and Cocaethylene on Agonist Responses
The ability o f pharmacologically active metabolites of cocaine to potentiate
responses to serotonin and norepinephrine (0.01 - 10 pM) was determined and

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

21
compared to cocaine. Concentration-effect curves for norepinephrine or serotonin
were constructed in log increments as described and then tissues were washed and
allowed to relax to basal tension. Tissues were incubated for at least 30 min with
buffer containing 10 pM concentrations of either benzoylecgonine, norcocaine, or
cocaethylene and concentration-effect curves to either serotonin or norepinephrine
were reconstructed in the presence of one of these metabolites. The addition of
metabolites was randomized to the control and each tissue served as its own
control. Metabolite concentrations of 10 pM were used to assure complete
blockade o f the uptake-1 site.

Determination o f Alpha, Receptor Presence
In order to determine alpha, receptor presence in human umbilical arteries
additions o f methoxamine, a potent alpha, receptor agonist, were made. Additions
were made in log increments over the concentration range 0 .0 1 -1 0 pM. These
additions were also made in the presence of 10 pM cocaine.

Ability o f Ketanserin to Attenuate Effects o f Cocaine
In order to assess the ability of ketanserin to attenuate the enhanced effects
o f cocaine on human umbilical arteries, rings were exposed to either
norepinephrine or serotonin alone, with cocaine, or with ketanserin and cocaine.
Rings were exposed to cumulative concentrations (0.01 -1 0 pM in 0.5 log
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increments) of either norepinephrine or serotonin. After tension equilibrated back
to baseline the tissues were incubated for 30 min with cocaine (IOjiM) and the
concentration-effect curves to norepinephrine and serotonin were reconstructed in
the presence or absence of buffer containing ketanserin (0.03 pM), this
concentration should have produced a 30-fold shift in the concentration-effect
curve for serotonin. The combinations of norepinephrine or serotonin alone, with
cocaine, or with cocaine and ketanserin were randomized.

Membrane Binding Studies

Tissue Preparation and Storage
Umbilical arteries for these studies were matched to umbilical artery
samples used in the ketanserin isolated tissue contractile studies. At the time of
the isolated tissue studies, an additional sample o f each artery, 2 cm in length, was
cleaned as previously described and immediately frozen on dry ice. Tissue
samples were stored at -80°C until processed for membrane binding studies.

Membrane Preparation
Arterial sections were thawed at room temperature and wet weights were
determined using a digital balance. Tissue samples were cut into small ( 2 x 2 mm)
pieces with surgical scissors under 2ml of ice-cold 250 mM sucrose solution in a
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small dish, then transferred to a 25ml polystyrene tube along with an additional 5
ml o f sucrose solution for a total o f 7 ml and homogenized with a Tekmar
Tissuemizer (Cincinnati, OH) at high speed for 20 sec. This homogenate was
transferred to a cold 7 ml ground glass tissue grinder and manually homogenized,
then transferred back to the polystyrene tube for low speed centrifugation with a
Beckman Model J-6 centrifuge (Beckman Instruments, Irvine, CA) at 1086 g for
10 min at 0°C. The supernatant was diluted 10-fold with Tris buffer (50 mM, pH
7.7), and centrifuged with a Beckman Model L5-65B utracentrifuge (Beckman
Instruments, Irvine, CA) at 50,000 g for 15 min at 0°C. The supernatant was
discarded and the pellet was resuspended in 12.5 ml o f fresh Tris buffer. The
membrane suspension was frozen at -80°C until the binding experiments were
conducted (see Figure 2 on the following page for a diagram o f the preparation
scheme).

Binding Assay Procedure

Protein Assay. Aliquots (100 pi) o f the membrane preparation samples in
Tris buffer were assayed for protein content with bovine serum albumin as the
protein standard using Bradford (1976) microtiter plate protocol, see Appendix E
for protocol.
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Competitive Binding Assay. The binding characteristics o f unlabeled ketanserin,
mianserin, serotonin, or tyramine (0.001 pM - 100 pM), and norepinephrine (10
pM) were determined by competitive binding o f these agents with 3H-ketanserin.
The assay was performed using the Millipore Multi-Screen Filtration System, this
96-well plate contained individual 1.2 pm glass fiber type C filters. The assay
was carried out in these wells on ice with 0.7 - 1.0 pg protein per 100 p i , 3 nM of
3H-ketanserin (50 pi), and 100 pi of competitive drug for a total volume of 250 pi
in each. Competitive binding assays for serotonin, norepinephrine, and tyramine
also included 10 pM pargyline and 0.1% ascorbic acid to prevent their metabolism
during incubation. All buffers and drug dilutions were kept ice-cold and additions
were made on ice. The plates were incubated in a Reciprocal Shaking Bath Model
25 (Precision Scientific, Chicago, IL) for 20 min at 37° C, pH 7.4 with agitation
(60 cycles per min).
At the end o f the incubation period, the plates were quickly removed from
the incubator and placed in the Millipore vacuum manifold. Contents of the wells
were vacuum filtered and washed once with 250 pi Tris buffer (room temperature).
Each filter was removed from the plate and placed in a 7 ml scintillation vial with
4 ml o f CytoScint (Fisher Biotech, Pittsburgh, PA) scintillation cocktail. Vials
were counted for 10 min each in a Wallac model 1409 liquid scintillation counter
(Gaithersburg, MD).
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Calculations and Statistics

Contractile Studies
Data are represented by the mean ± standard error o f the mean (S.E.M.)
responses expressed as a percent o f the paired, KC1 maximum, for 5 subjects.
Data representation by this method decreased the variation between subjects and
allowed for more rigorous comparisons. Concentration-effect curves were
compared by several different methods. Comparisons were always made for each
dose o f agonist in the presence and absence of cocaine using paired Student’s ttests. Cumulative response was further analyzed by calculation o f the area under
the concentration-effect curve for each tissue in the presence and absence of
cocaine using the trapezoidal rule (Wagner 1979). The area under the
concentration-effect curve was defined as:

I1/2(0 , + c ^ -

ro,

where C = molar concentration o f drug and R = % KC1 Max. ECS0 and ECl5
values, the mean effective concentrations to produce either 50 or 15% o f the
maximum response to KC1, were calculated from log interpolation o f each
concentration-effect curve. Dissociation constants (KB) for norepinephrine and
serotonin were calculated using the equation from Kenakin et al. (1992),
log IDose Ratio-1] = log [Antagonist] - log KB,
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where the dose ratio is the ECS0 after antagonist addition / ECS0 before antagonist
addition and [Antagonist] is the concentration o f ketanserin (0.03 (iM).
Levels o f p<0.05 were accepted as statistically significant differences
between groups compared. Statistical comparisons were made on a GATEWAY
2000 Personal Computer P5-166 XL and PROSTATstatistics package version 1.50
and PSI-PLOT graphics package version 5.0, (Poly Software International, Salt
Lake City, UT). Graphs were created using Graphpad PRISM version 2.01
graphics package, (Graphpad Software, Inc., San Diego, CA).

3H-Ketanserin Binding Studies
Data obtained from the radioligand binding assays were converted from
disintegrations per minute to picomoles o f binding per milligram o f protein using
the Graphpad PRISM graphics package on a personal computer as previously
described. The saturation binding curve for 3H-ketanserin was determined from
the unlabeled ketanserin displacement curve. These values were then used to
determine the binding maximum (Bmax) and dissociation constant (IQ) of 3Hketanserin in the protein samples obtained from human umbilical arteries matched
to ketanserin isolated tissue studies. Using Graphpad PRISM nonlinear regression
analysis, the data were fit to the equation:
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Z? _[Ligand!
Total Binding =

___________________ +

N [Ligand],

Kd+[Ligand]

where N * [Ligand] represents the nonspecific binding of the ligand. The Bmax
represents the maximum number of specific binding sites in pmoles per mg protein
and K<j represents the dissociation constant in nM o f 3H-ketanserin for the binding
site.
The data from the competitive binding studies were transformed to percent
o f control binding for each o f the displacing ligands. These values were then fit to
a one or two site binding equation based on the calculated best fit using the
Graphpad PRISM curve fitting program and the sequential F-test.
One site competition equation:
y = bottom + (top-bottom) / (1 + 10 A(x-log EC50))
Two site competition equation:
y = (bottom+top) * fraction 1/ (1 + 10 A (x-log EC50_1)) +
(bottom+top) * (1-fraction 1)/ (1 + 10 A(x-log EC50_2))
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Materials and Chemicals

Contractile Studies
(-)-Norepinephrine bitartrate, tyramine hydrochloride, 5-hydroxytryptamine
hydrochloride, methoxamine hydrochloride, and dopamine hydrochloride, were
purchased from Sigma Chemical Co., (St. Louis, MO). Norcocaine hydrochloride,
cocaethylene hydrochloride, benzyolecgonine, cocaine hydrochloride, and
ketanserin tartrate were purchased from Research Biochemicals International,
(Natick, MA). All drugs were dissolved and diluted with ultra pure deionized
distilled water (18 mOhm). Chemicals for modified Krebs-Henseleit buffer were
purchased from Fisher Scientific (Pittsburgh, PA).

Binding Studies
Ketanserin hydrochloride, [ethylene-3H]-(R41 468), specific activity range
60-90 Ci/mmol, > 97% radiochemical purity was obtained from New England
Nuclear Life Science Products, Inc. (Boston, MA). Unlabeled competitive binding
agents norepinephrine bitartrate, 5-hydroxytryptamine hydrochloride, and tyramine
were purchased from Sigma Chemical Co. (St. Louis, MO) and dissolved and
diluted in Tris buffer, pH 7.7. Ketanserin tartrate, and mianserin hydrochloride
were purchased from Research Biochemicals International, (Natick, MA),
dissolved in 0.1 N HC1 and diluted with Tris buffer. L-ascorbic acid and
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biological grade tris, and CYTOSCINT scintillation cocktail was obtained from
Fisher Biotech, (Fair Lawn, NJ). Pargyline hydrochloride was purchased from
Regis Chemical Co.
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CHAPTER 3
RESULTS

Contractile Studies in the Human Umbilical Artery

Normal Contractile Function
The exposure o f umbilical artery rings to 65 mM KC1 produced a rapid
increase in contractile force that reached a maximum within 30-60 seconds and
was sustained at a steady tonic phase for 2-3 min (Figure 3). Responses to KC1
were stable over the course o f the experimental time frame o f 5-6 hours. Tyramine
produced a similar response also shown in Figure 3, contractions to tyramine were
also stable over a 2-3 hour period.

KCI

TYRAMINE

TYRAMINE

1 gm
S m in

Figure 3. Typical isometric responses to 65mM KCI and tyramine.
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Isolated umbilical artery rings were used to produce concentration-effect
curves for norepinephrine and serotonin over the concentration range 0.01 - 10
pM, these concentration-effect curves were repeatable and remained stable for up
to 5 hours.

Assessment of Innervation
In order to assess the presence o f innervation in the isolated umbilical artery
tyramine was added to the preparation in 10 and 100 pM concentrations as
previously described in the Materials and Methods section. Tissues were also
exposed to tyramine in the presence o f 10 pM cocaine. Tyramine (10 pM)
produced a slight vasoconstrictive response. Addition of cocaine (lOpM) did not
significantly potentiate this response (Figure 4). The mean vasoconstrictive
response to tyramine (100 pM) was significantly increased by 257% (p<0.05), in
the presence of cocaine (lOpM) in comparison to tyramine alone at 100 pM
(Figure 4).
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Figure 4. Effect of cocaine (10 pM) on the vasoconstrictive response to
tyramine. Data are presented as mean ± S.E.M. for paired tissue comparisons,
n=6,* p< 0.05.

Agonist Responses in the Presence o f Cocaine

Effect of Cocaine on Serotonin Responses. The dose-response curves for
serotonin in the presence and absence of cocaine (lOpM) are presented in Figure 5.
Cocaine produced a potentiation o f the vasoconstrictive response to serotonin. In
the presence of cocaine, the mean vasoconstrictive effect o f serotonin from 0.1 pM
to 10 pM was potentiated by 28% (p<0.05). In the presence o f cocaine, the tissue
was more sensitive to serotonin. The area under the concentration-effect curve for
serotonin in the presence of cocaine was significantly greater (p<0.05) than the
area for serotonin alone (Table 1).
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Figure 5. Effect of cocaine (10 pM) on the vasoconstrictive response to
serotonin. Data are presented as the mean ± S.E.M of paired tissue
comparisons, n=6, * p<0.05.
TABLE 1.
Area under the cumulative concentration-effect
curve* for serotonin and norepinephrine in the presence and absence of cocaine.
Neurotransmitter

Neurotransmitter Alone

Neurotransmitter with Cocaine

Norepinephrine

176.19

614.87*

(51.30)

(203.49)

1071.65

1355.50*

Serotonin

(42.58)
Data is the mean (S.E.M.) of 6 paired observations.

(111.82)

* indicates statistical significance (p<0.05).
* Area under the cumulative concentration effect curve is defined as
E 1/2(C, -K^O^R-i) where C = concentration of neurotransmitter and
R = %contraction (KC1 max)/ pM concentration.
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Effect of Cocaine on Norepinephrine Responses. The concentration-effect
curves produced by norepinephrine in this model were reproducible and the
contractile response was induced in a dose-dependent manner. The concentrationeffect curves for norepinephrine in the presence and absence o f cocaine (10|iM)
are presented in Figure 6 . Cocaine potentiated the sensitivity to norepinephrine by
about 25% at lower doses and by 64% at the maximum response to norepinephrine
(10 pM) significantly, (p<0.05). The area under the concentration-effect curve for
norepinephrine in the presence of cocaine was significantly greater than the area
for norepinephrine alone (p<0.05), (Table 1). Cocaine produced a 60-fold,
leftward shift in the concentration-effect curve. This indicates greater sensitivity
o f the umbilical artery to norepinephrine in the presence o f cocaine.
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Figure 6. Effect of cocaine (lOpM) on the vasoconstricitve response to
norepinephrine. Data are presented as the mean ± S.E.M. of paired tissue
comparisons, n=6, *p< 0.05.
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Agonist Responses in the Presence o f Benzovlecgonine

Effect of Benzoylecgonine on Serotonin Responses. The concentrationeffect curves for serotonin alone and in the presence o f benzoylecgonine are
presented in Figure 7. Benzoylecgonine produced a decrease in the contractile
response o f the umbilical artery to serotonin, this effect was significant at 1 and
10 pM where the responses were reduced by 36 and 30% respectively. The shift
o f the concentration-effect curve to the right indicates a decrease in sensitivity to
serotonin in the presence o f benzoylecgonine. The area under the cumulativeconcentration effect curve values for serotonin in the presence o f benzoylecgonine
were significantly less than for serotonin alone (Table 2).
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Figure 7. Effect of benzoylecgonine (10 |iM) on the vasoconstrictive reponse to
serotonin. Data are presented as the mean ± S.E.M. of paired tissue responses,
n=4, * p<0.05.
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TABLE 2.
Area under the cumulative concentration-effect curve+for serotonin and
norepinephrine in the presence and absence of benzoylecgonine
Neurotransmitter

Neurotransmitter alone

Neurotransmitter with
benzoylecgoninne

Norepinephrine

Serotonin

404.25

452.25

(162.13)

(196.67)

1057.5

714.0*

(20.3)

(124.5)

Data is the mean (S.E.M.) of 4 paired observations
* indicates statistical significance (p<0.05).
* Area under the cumulative concentration effect curve is defined as
S 1/2(C, +C2)(R2-R,) where C = concentration of neurotransmitter
R =% contraction (KC1 max)/ pM concentration.
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Effect of Benzoylecgonine on Norepinephrine Responses. The
concentration-effect curves for norepinephrine in the presence and absence of
benzoylecgonine are presented in Figure 8. Benzoylecgonine produced no
significant differences on the responses o f the isolated umbilical artery to
norepinephrine. Benzolyecgonine did shift the EC 15 for norepinephrine to the
right 4.5 fold, indicating decreased sensitivity of the tissue to norepinephrine in the
presence of benzoylecgonine.
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Figure 8. Effect of benzoylecgonine (10 pM) on the vasoconstrictive response to
norepinephrine. Data are presented as paired tissue comparisons, mean ± S.E.M.,
n=4.
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Agonist Responses in the Presence o f Norcocaine

Effect o f Norcocaine on Serotonin Responses. Concentration-effect curves
for serotonin in the presence and absence o f norcocaine (10 pM) are presented in
Figure 9. Serotonin responses in the presence of norcocaine were not significantly
different from control responses. Norcocaine did produce a slight leftward shift in
the concentration-effect curve for serotonin and a slight potentiation of the
maximum response (22%).
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Figure 9. Effect of norcocaine (lOpM) on the vasoconstrictive response to
serotonin. Data are presented as paired tissue comparisons, mean ± S.E.M.
n=6.
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Effect of Norcocaine on Norepinephrine Responses. The concentrationeffect curves for norepinephrine in the presence and absence o f norcocaine
(10 pM) are presented in Figure 10. Norcocaine significantly potentiated the
maximum response to norepinephrine by 54%, p<0.05 . EC50 values and area
under the concentration-effect curve values for norepinephrine alone and
norepinephrine in the presence o f norcocaine were not significantly different, due
to large variations among tissue responses.
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Figure 10. Effect of norcocaine (lOpM) on the vasoconstrictive response to
norepinephrine. Data are presented as the mean ± S.E.M. of paired tissue
comparisons, n=6, *< p 0.05.
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Agonist Responses in the Presence o f Cocaethylene

Effect o f Cocaethvlene on Serotonin Responses. The responses o f the
isolated human umbilical artery to serotonin in the presence and absence of
cocaethylene are presented in Figure 11. Cocaethylene did not potentiate the
concentration-effect curve to serotonin significantly. An increase in maximum
responses o f 23% indicates increased sensitivity to serotonin o f the tissue in the
presence o f cocaethylene.
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Figure 11. Effect of cocaethylene (10 pM) on the vasoconstrictive response to
serotonin. Data are presented as the mean ± S.E.M. of paired tissue
comparisons, n=7.
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Effect o f Cocaethylene on Norepinephrine Responses. The concentrationeffect curves for norepinephrine alone and in the presence of cocaethylene are
presented in Figure 12. Cocaethylene potentiated the maximum response to
norepinephrine by 44%. The leftward shift of the concentration-effect curve
indicates greater sensitivity o f the tissue to norepinephrine in the presence of
cocaethylene. There were no significant differences between concentration-effect
curves despite the obvious effect of cocaethylene, this is probably due to large
variations among tissue responses.
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Effect of cocaethylene (10 |iM) on the vasoconstrictive response to
norepinephrine. Data are presented as the mean ± S.E.M. of paired tissue
comparisons, n=7.
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Comparison o f Potency Between Cocaine and Metabolites
Area under the concentration-effect curve values were determined for
serotonin and norepinephrine in the presence or absence of cocaine and its
metabolites. The differences in the concentration-effect curves between the
presence or absence o f cocaine or its metabolites for each neurotransmitter were
calculated and used to perform a multiple comparisons analysis of variance
between effects o f cocaine and its metabolites. The mean values for the area under
the concentration-effect curve differences for serotonin in the presence or absence
of cocaine or metabolites are presented in Table 3. The mean values for area under
the concentration-effect curve differences for norepinephrine in the presence and
absence of cocaine or metabolites are presented in Table 4. The effect for
serotonin with cocaine, norcocaine, or cocaethylene was significantly greater than
that o f serotonin with benzoylecgonine. The order of potency for cocaine and its
metabolites based on the greatest to the least effect between the presence and
absence of cocaine or metabolite in response to serotonin and norepinephrine is:
cocaine>norcocaine>cocaethylene»»benzoylecgonine.
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TABLE 3.

Cummulative effects"- for serotonin in the
presence or absence of cocaine or metabolites.
Serotonin / Cocaine
283.80 (109.49)

Serotonin /
Benzoylecgonine
-351.00* (139.35)

Serotonin /
Norcocaine

Serotonin /
Cocaethylene

201.85 (103.18)

141.28 (89.62)

* p<0.05
+Data is the mean, % contraction (KC1 MAX)/ pM concentration, (S.E.M.) of 4-7 paired
observations.

TABLE 4.
Cummulative effects* for norepinephrine in the presence of cocaine or metabolites.
Norepinephrine/
Cocaine

Norepinephrine/
Benzoylecgonine

Norepinephrine/
Norcocaine

Norepinephrine/
Cocaethylene

439.52 (167.26)
48.00 (38.42)
320.46 (156.28)
262.31(125.88)
+Data is the mean, % contraction (KC1 MAX)/ pM concentration, (S.E.M.) of 4-7 paired
observations.
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Domination o f Alphat Receptor Presence
Additions of methoxamine, a potent alpha, agonist, were made to tissue
bath preparations. The addition o f increasing concentrations o f methoxamine
(0.01 - 10 pM) produced no effect on the human umbilical artery. There was no
change from baseline tension over the entire concentration range.

Effect o f Ketanserin on Cocaine Potentiation o_f Serotonin Responses
The concentration-effect curves for serotonin alone, serotonin with cocaine,
and serotonin with cocaine and ketanserin are presented in Figure 13. Calculated
EC50's for each drug combination are given in Table 5. Cocaine potentiated the
response to serotonin as shown by the leftward shift of the concentration-effect
curve to serotonin in the presence o f lOpM cocaine. Ketanserin (0.03 pM) was
able to attenuate the enhanced vasoconstriction produced by cocaine. Ketanserin
significantly increased the EC50 for serotonin with cocaine, shifting the EC50 to

the right 10-fold (p<0.05). The calculated pKBvalue (log [dose ratio - 1] = log
[antagonist] - log KB) for serotonin with cocaine was 8.30. Ketanserin was also
able to significantly depress the response to serotonin at 0.03 |iM and 0.1 jiM by
87% and 102% respectively (p<0.05) in the presence of cocaine (lOpM).
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Figure 13. Effect of ketanserin (0.03 pM) on the potentiation of serotonin by
cocaine (10 pM). Data are presented as the mean ± S.E.M. of paired tissue
comparisons, n=5 , * p<_0.05.

TABLE 5.
EC50 values for serotonin alone, with cocaine and
with cocaine and ketanserin.
Serotonin

0.049 ± .006 pM

Serotonin / Cocaine

0.022 ± .005 pM

Serotonin / Cocaine /
Ketanserin

0.32 ± .09 pM *

Data is the mean ± the S.E.M.
* - Significantly different from serotonin with cocaine, p<0.05
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Effect o f Ketanserin on Cocaine Potentiation ofNorepinephrine Responses
The concentration-effect curves for norepinephrine alone, norepinephrine
with cocaine, and norepinephrine with cocaine and ketanserin are presented in
Figure 14. EC 15 values, were calculated and used for comparison because this is
the responses at which parallel shifts in the concentration-effect curves for
norepinephrine can best be compared. The EC 15 values for each drug
combination are given in Table 6. Cocaine was able to potentiate the
concentration-effect curve to norepinephrine as shown by the 205-fold leftward
shift o f the EC 15 in the presence o f 10pM cocaine. The potentiation o f
norepinephrine by cocaine was completely attenuated by ketanserin (0.03 fiM) in
this tissue. Ketanserin produced a 205-fold rightward shift o f the EC 15 to
norepinephrine in the presence o f cocaine. The calculated pKBvalue for
norepinephrine with cocaine was 9.17. Ketanserin significantly depressed the
maximum response to norepinephrine by 54% at 1 pM (p<0.05) in the presence of
lOpM cocaine.
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Figure 14. Effect of ketanserin (0.03 pM) on the potentiation of norepinephrine by
cocaine (10 pM). Data are presented as the mean of paired tissue comparisons, n=5,
*p<0.05.

TABLE 6.
EC 15 values for norepinephrine alone, with cocaine, and with cocaine and ketanserin.
Norepinephrine/Cocaine

0.79 ± 0.05 pM

Norepinephrine/Cocaine/
Ketanserin

3.6* ± 1.5 pM

Data is the mean (standard deviation).
* - Significantly different from norepinephrine with cocaine, p<0.05
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3H-Ketanserin Membrane Binding Studies

^H-Ketanserin Saturation
Umbilical arteries were homogenized and prepared as described in the
Materials and Methods. The membrane fraction was assayed for serotonin^ and
serotonin2c binding characteristics. The binding maximum (Bmax) and the
dissociation constant (K J for 3H-Ketanserin was calculated using Graphpad
PRISM nonlinear regression analysis. The binding characteristics of 3HKetanserin fit best to a one site binding equation as determined by the sequential
F-test. Bmax was 14.610 nmol/mg, KDwas 241.6 nM, and the non-specific binding
was 112.204 nmol/mg. The saturation curve for 3H-Ketanserin is presented in
Figure 15.

150
125
0 o 100

5 o.
Q o> 75
Z E
ffi

K0 = 2 4 1 .6 nM

50

Bmax «112.2 nmol/mg

25.

25
[KETANSERIN] (nM)
Figure 15. 3H-ketanserin saturation binding characteristics. Data are
presented as the mean ± S.E.M., n=6.
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Displacement o f 3H-Ketanserin bv Mianserin
3H-ketanserin was competively displaced by mianserin, a serotonin2aib>&c
antagonist. The KDfor mianserin was 0.29 ± .083 jxM, the displacement curve fit
best to the one-site competition equation according to the sequential F-test, F =
5.746 and p = 0.01629. The displacement curve for mianserin presented in Figure
16.
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Figure 16. Mianserin displacement of 3H-ketanserin (3 nM). Data are presented
as the mean ± S.E.M., n=6.
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Serotonin Displacement o f 3H-Ketanserin
Serotonin competitively displaced 3H-ketanserin. The displacement curve
for serotonin fit best to the two-site competition equation, F = 6.2 and p = 0.04
with a K d 2.8 ± 1.9 nM for one site and a KD2.7 ± 0.72 pM for the second site.
The displacement curve for serotonin is presented in Figure 17.
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Figure 17. Serotonin displacement of 3H-ketanserin (3 nM). Data are
presented as the mean ± S.E.M., n=6.
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Tyramine Displacement of 3H-Ketanserin
Tyramine was able to displace 3H-ketanserin at two sites as determined by
the sequential F-test, F = 21.56 and p = 0.011. The KD for one site was 7.88 ± 7.82
nM and the KD for the second site was 36.24 ± 32.44 pM The displacement curve
for tyramine is presented in Figure 18.
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Figure 18. Tyramine displacement of 3H-ketanserin (3 nM). Data
are presented as the mean ± S.E.M., n=6.
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Norepinepinephrine Displacement o f 3H-Ketanserin
Norepinephrine produced minimal displacement o f 3H-ketanserin, only 4%
o f total binding was displaced (Figure 19). Even at a concentration o f 10 pM
norepinephrine were there was no significance difference from the control.
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Figure 19. Norepinephrine displacement of 3H-ketanserin (3 nM).
Data are presented as the mean ± S.E.M., n=6.
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CHAPTER 4
DISCUSSION

The in vitro toxicity o f cocaine and its metabolites and the antidotal
potential for ketanserin in human umbilical artery toxicity produced by cocaine
were examined in this study. Cocaine abuse has been implicated in a number of
perinatal complications presumably arising from the vasoconstrictive actions of
cocaine such as placental abruption and preterm labor. Studies conducted in the
isolated ovine (Dyer 1970) and guinea pig (Nair and Dyer 1974) umbilical arteries
have provided evidence that cocaine may potentiate serotonin and norepinephrine
constriction o f umbilical arteries. Several cocaine metabolites, benzoylecgonine,
norcocaine, and cocaethylene seem to possess pharmacological activity similar to
cocaine itself, in that all three produced vasoconstriction o f fetal cerebral porcine
arterioles (Kurth et al. 1993). Tuncer et al. (1985) reported that ketanserin and
mianserin antagonized serotonin induced contractions o f human umbilical artery
strips, and ketanserin has been touted as a safer alternative to hydralazine in
perinatal hypertension (Rossouw et al. 1995).
Innervation of the human umbilical artery was investigated using tyramine,
an indirect acting sympathomimetic, in an isolated tissue model. Concentrations
o f tyramine were added to the baths to produce vasoconstriction which should be
54
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abolished by the addition of cocaine. The ability o f cocaine to produce enhanced
contractile responses to serotonin and norepinephrine in the isolated umbilical
artery ring model was analyzed. Cocaine metabolites, benzoylecgonine,
norcocaine, and cocaethylene were also examined for their ability to enhance
responses to serotonin and norepinephrine. The serotonin2 antagonist ketanserin
was used to delineate the question o f receptor types involved in cocaine
potentiation o f vasoconstrictive responses. Membrane binding studies were
conducted using 3H-ketanserin to determine the displacement characteristics of
mianserin, serotonin, tyramine, and norepinephrine at serotonin2 receptors in the
smooth muscle o f the umbilical artery.

Innervation o f the Isolated Human Umbilical Artery
The innervation o f the umbilical vasculature has been a topic of controversy
for several decades. Even as recently as 1990 the conflict continued; no evidence
o f innervation in the umbilical vasculature was initially demonstrated using
immunohistological and histochemical techniques (Fox and Khong 1990), yet in
another study the presence of adrenergic and cholinergic nerve fibers were
revealed in umbilical arteries at the fetal end o f the human umbilical cord using
histochemical techniques (Kawano and Mori 1990). The possibility o f adrenergic
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innervation in human umbilical artery suggests a role for cocaine in potentiating
vasoconstriction produced by norepinephrine and serotonin.
Tyramine is an indirect-acting sympathomimetic substance which produces
a pressor response in other tissues by producing norepinephrine release from
presynaptic nerve terminals (Figure 20). The vasoconstrictive effect o f tyramine in
other tissues is abolished or inhibited by cocaine's blockade o f the presynaptic
uptake of tyramine.

PRESYNAPTIC TERMINAL
uptake-1 site

V

POSTSYNAPTIC TERMINAL

alpha-1 receptor
^ vasoconstriction

norepinephrine

V

tyramine

O

vesicle

Figure 20. Diagrammatic representation of the pharmacological mechanism of
tyramine. Tyramine displaces norepinephrine from presynaptic nerve terminals,
norepinephrine binds to post-synaptic alpha, adrenoceptors to produce
vasoconstriction.
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Tyramine produced only a minimal response at a concentration o f 10 pM which
may be due to limited norepinephrine containing presynaptic nerve terminals and
lower alpha! adrenoceptor density than would normally be present in arterial
smooth muscle. The weak response o f the umbilical artery to norepinephrine
supports this concept. At a 100 pM tyramine concentration, there was a
vasoconstrictive response, which was significantly greater in the presence o f
cocaine (lOpM). The potentiation by cocaine produced a vasoconstrictive
response to tyramine that was similar in magnitude to the KC1 maximum. These
results are similar to the findings of Gulati and Kelkar (1970); their study
demonstrated a 20% potentiation o f vasoconstrictive responses to tyramine in the
isolated human umbilical cord perfusion model by cocaine. These results provide
functional evidence that umbilical arteries are innervated and tyramine is
producing its effects at an unidentified postsynaptic receptor. The paradoxical
potentiation o f tyramine-induced vasoconstriction by cocaine in umbilical arteries
suggests that the effect o f cocaine to inhibit its uptake into the nerve terminal is
exacerbating this direct effect. It is also possible that the endothelium-dependent
mechanism proposed by Zhang and Hu (1998) for serotonin potentiaion by cocaine
may be applicable to tyramine potentiation by cocaine as well.
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Cocaine Enhancement o f Vasoconstrictive Responses
to Norepinephrine and Serotonin
Exposure o f the human umbilical artery to serotonin produced repeatable
contractions that were significantly enhanced by cocaine. The concentration-effect
curve for serotonin in the presence o f cocaine was shifted to the left indicating
greater sensitivity o f the tissue to serotonin in the presence o f cocaine (10 pM). A
vasoconstrictive response to norepinephrine was produced at very high
concentrations and there was a significant potentiation o f this response in the
presence of cocaine. Cocaine also produced a leftward shift o f the concentrationeffect curve to norepinephrine indicating enhanced sensitivity of the tissue to
norepinephrine in the presence of cocaine as well.
These results are analogous to the findings o f Nair and Dyer (1974), who
observed cocaine potentiation of serotonin and norepinephrine contractions in
guinea pig umbilical artery strips. Gulati and Kelkar (1970) noticed that
norepinephrine but not serotonin effects were potentiated by cocaine in the
umbilical cord perfusion model. Dyer (1970) as well as Zhang and Hu (1998)
produced cocaine potentiation o f serotonin contractions in isolated ovine umbilical
arteries. Dyer (1970) concluded that cocaine potentiation was produced by
inhibition o f neuronal reuptake of serotonin based on significant decrease o f 3Hserotonin uptake. Dyer (1970) also noted that the addition o f desmethylimipramine
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along with cocaine did not produce an exacerbation o f this effect. Zhang and Hu
(1998) attributed cocaine potentiation o f serotonin contractions to the presence o f
endothelium. In their study, removal o f the endothelium abolished the enhanced
contractile effect of serotonin in the presence o f cocaine. It is unclear whether
cocaine is primarily inhibiting the reuptake o f norepinephrine and serotonin into
the presynaptic nerve terminal, limiting the major means o f inactivation for these
neurotransmitters and/or by preventing serotonin-stimulated release of endothelialrelaxing factor as proposed by Zhang and Hu (1998) in the ovine umbilical artery.
Kopin et al. (1984) estimated the mean synaptic concentration of
norepinephrine to produce a 50 mm Hg increase in mean arterial pressure in pithed
rats to be 7 nM. They demonstrated that treatment with desipramine produced a 3fold increase in this concentration; this is within the concentration range of
norepinephrine we used and observed a vasoconstrictive potentiation with cocaine.
Like cocaine, desipramine blocks neuronal uptake and this effect at a synaptic
junction in vivo supports the clinical relevance of the effect we observed in vitro
with similar concentrations o f norepinephrine.
Bodelsson and Stjemquist (1995) did not observe a potentiation o f
norepinephrine in the presence of a 1 pM (0.3 pg/mL) concentration o f cocaine, a
therapeutic to subtoxic plasma concentration in humans (therapeutic range o f 0.050.31 pg/mL, Winek 1994; Ellenhom et al. 1997). Our cocaine concentration o f 10
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pM (3.0 pg/mL), is comparable to a toxic to potentially lethal plasma cocaine level
in humans (toxic to lethal range o f 0.9-21 pg/mL, Winek 1994; Baselt and Cravey
1995). This suggests that the degree o f significant constriction in the umbilical
artery is dependent upon cocaine concentration and is produced by relatively
higher plasma concentrations o f cocaine which may occur with prolonged abuse or
toxic dosage. This situation is possible and especially relevant in the umbilical
artery since pregnancy decreases the metabolism o f cocaine and increases the
maternal half-life o f cocaine and its metabolites (Neale and Parks 1973).
Plessinger and Woods (1990) found that progesterone is involved in producing
greater cardiovascular sensitivity to cocaine. In their study they found that
cardiovascular toxicity in non-pregnant ewes was increased when progesterone
was administered intramuscularly. Progesterone also increases the sensitivity of
contractile alpha adrenoreceptors. Since progesterone concentrations increase with
gestation, if the effects of cocaine are potentiated by progesterone, then cocaine
use by the mother in the later stages o f pregnancy would pose potentially greater
risk for toxic vasoconstrictive effects.
Serotonin is a potent vasoconstrictor o f umbilical arteries and cocaine has
been shown to inhibit the neuronal reuptake of this substance in the brain (Ritz et
al. 1990). We did produce a significant potentiation of the vasconstrictive
response to serotonin in the isolated human umbilical artery, demonstrating that
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both norepinephrine and serotonin could be involved in the acute vascular toxicity
o f perinatal cocaine abuse. This information is particularly important considering
that the vasconstrictive effects o f norepinephrine are augmented by serotonin (Van
Neuten et al. 1985). The simultaneous potentiation o f norepinephrine and
serotonin by cocaine and augmentation o f these effects by the neurotransmitters
themselves could result in a toxic and potentially lethal pressor response o f the
umbilical artery to the fetus.

Potentiation o f Norepinephrine and Serotonin Effects bv Cocaine Metabolites
Cocaine metabolites shown to exhibit vasoconstrictive and hemodynamic
effects similar to or exceeding those of cocaine were examined in this study for
their ability to enhance the contractile responses to serotonin and norepinephrine in
the isolated human umbilical artery. Benzoylecgonine, norcocaine, and
cocaethylene were added to the preparation in the same manner described for
cocaine, concentration-effect curves were constructed for serotonin and
norepinephrine in the presence or absence o f each metabolite. The effects o f these
metabolites were compared to cocaine by calculating the difference between area
under the curve values for serotonin and norepinephrine with or without cocaine or
metabolite; these differences were compared using a multiple comparisons
analysis of variance and Fisher’s LSD.
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Benzoylecgonine (10 pM) decreased in the m axim um response to serotonin
in this study by as much as 36%. The human umbilical artery was less sensitive to
serotonin in the presence o f benzoylecgonine as shown by the significant decrease
in the area under the concentration-efFect curve. Benzoylecgonine did not produce
significant effects on norepinephrine responses in this study. There was a leftward
shift of the EC 15 in the concentration-effect curve for norepinephrine in the
presence o f benzoylecgonine, but the maximum response remained unchanged.
Benzoylecgonine does produce effects alone in vivo and in vitro. These effects
include increased cerebral vascular resistance in fetal lambs (Covert et al. 1994)
and vasoconstrictive effects on fetal pig cerebral arterioles (Kurth et al. 1993). An
in vitro study conducted by Madden and Powers (1990) using isolated cat cerebral
arteries also demonstrated vasoconstrictive effects produced by benzoylecgonine.
Norepinephrine induced constriction o f the fetal pig arterioles was not potentiated
by benzoylecgonine in the study by Kurth et al. (1994). Consistent with the
serotonin findings in the present study, Covert et al. (1994) did notice an increase
in fetal carotid blood flow in response to benzoylecgonine (peak serum
concentration 3.61 mg/ml) administration in one ewe.
Norcocaine produced a significant potentiation o f the maximum
norepinephrine response and increased the sensitivity o f the tissue to
norepinephrine. Consistent with results produced in fetal pig cerebral arterioles,
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norcocaine was able to significantly potentiate norepinephrine constriction of the
vessels and produced a significant decrease in arteriolar diameter (Kurth et al.
1994). No significant effects were observed for the response to serotonin in the

presence o f norcocaine (10 (iM). There was an increase in the maximum response
to serotonin, but this effect was not statistically significant due to variation in
tissue responsiveness.
In this study cocaethylene did not produce significant increases in
norepinephrine or serotonin vasoconstrictive responses of the human umbilical
artery. Kurth et al. (1994) observed significant potentiation of norepinephrine
induced constriction o f fetal pig cerebral arterioles by cocaethylene and the authors
reported cocaethylene to be a more potent constrictor of these arterioles than
cocaine itself. Although the maximum response to norepinephrine in the presence
o f cocaethylene (10 p.M) was increased almost as considerably as that of
norepinephrine with cocaine in this study, variation among tissue responses may
have masked the statistical significance o f cocaethylene enhancement.
Calculations o f cummulative effects between serotonin concentration-effect
curves before or after exposure o f the tissues to cocaine or a metabolite revealed
that effects o f cocaine, norcocaine, and cocaethylene were similar. The effect of
benzoylecgonine was significantly less than other metabolites due to decreased
sensitivity o f the tissue to serotonin in the presence o f this metabolite. For
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norepinephrine mediated contractions, calculated differences revealed that the
effects of cocaine, norcocaine, benzoylecgonine and cocaethylene were not
significantly different.

Effect o f Methoxamine in the Human Umbilical Artery
The response to norepinephrine produced in this study was minimal, and
methoxamine, a potent alpha, receptor agonist did not produce a vasoconstrictive
response the human umbilical artery. This suggests that norepinephrine is
producing its effect through receptors other than alpha, adrenoceptors. It is also
unlikely that norepinephrine produces constriction o f the umbilical artery through
stimulation of alpha2 adrenoceptors since Tuncer et al. (1985) were unable to
produce contraction of human umbilical artery strips with clonidine, an alpha2
selective agonist.

Ketanserin Attenuation of Cocaine Effects
We found that cocaine potentiates the maximum response to serotonin by as
much as 28%. This is indicative of a significant role for serotonin in the perinatal
toxicity which is seen with cocaine abuse. Tuncer et al. (1985) demonstrated
antagonism o f serotonin concentration-effect curves by ketanserin and mianserin
in the human umbilical artery. Although the pA2 values reported for these
antagonists were lower than those reported in other tissues, the parallel rightward
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shifts in the concentration-effect curves indicate that ketanserin may be useful in
pathological serotonin-mediated contractions o f the umbilical artery.
In these experiments ketanserin was able to antagonize the response to
serotonin in the presence of cocaine, indicating that serotonin2 receptors are
involved in the vasoconstrictive response to serotonin potentiated by cocaine.
Because serotonin is a very potent constrictor o f umbilical arteries and cocaine
potentiates this effect, ketanserin may be a useful agent in the treatment o f acute
perinatal cocaine toxicity which involves constriction o f placental, uterine, and
umbilical vasculatures.
We have also found that cocaine is able to produce a potentiation of
norepinephrine-mediated vasoconstriction. Cocaine does potentiate the maximum
response to norepinephrine by 64% (as noted in this study), however
norepinephrine is not a very potent constrictor of umbilical arteries alone
(Bodelsson and Stjemquist 1995). Methoxamine had no vasoconstrictive effect on
isolated human umbilical arteries in our preparation. This indicates that
norepinephrine may not be acting through alpha, receptors in this tissue. Based on
the responses to phenylephrine and the antagonism o f prazosin and rauwolscine at
alpha-adrenoceptors, Bodelsson and Stjemquist (1995) concluded that
norepinephrine was producing its effect through alpha, and alpha2 adrenoceptors.
In the same study, the authors noted that methysergide, a nonspecific serotonergic
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antagonist, antagonized the concentration-effect curve of oxymetazoline, an alpha2
agonist. In this study we examined the concept that norepinephrine may be
exerting its effects through serotonin2 receptors. We found that ketanserin
antagonized the potentiation o f norepinephrine by cocaine. The concentrationeffect curve to norepinephrine with cocaine was shifted 60-fold to the right in the
presence o f ketanserin and cocaine, which was a complete attenuation of the
potentiation produced by cocaine. This indicates that norepinephrine stimulation
o f serotonin2 receptors may be a significant component o f the enhanced response
to norepinephrine produced by cocaine.
We have demonstrated that the vasoconstrictive effects o f both
norepinephrine and serotonin are potentiated by cocaine. The toxic potential of
this situation is magnified by the concept that simultaneous stimulation of alphaadrenoceptors and serotonin receptors is not merely additive but results in
potentiation (Van Nueten et al. 1985). Since ketanserin is able to antagonize
cocaine potentiation o f the responses to both norepinephrine and serotonin in the
umbilical artery, this suggests a clinical role for ketanserin in the treatment of
acute perinatal cocaine toxicity situations.
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3H-Ketanserin Membrane Binding Studies
In this study the binding characteristics o f 3H-ketanserin were determined in
the membrane fraction o f homogenized human umbilical artery sections.
Umbilical artery membrane fractions were paired to the tissues used in the
ketanserin attenuation contractile studies. Specific and saturable binding o f 3Hketanserin was produced, the KDand Bmax values calculated from the results o f this
study were much higher than those reported by Hu and Zhang (1997) for 3Hketanserin in the ovine uterine artery (KD 1.46 ± .38 nM and Bmax 31.9 ± 5.9 ftnol /
mg protein). Similar results were obtained by Jazayeri et al. (1989) in the rat
aortic smooth muscle cell (KD 1.63 ± 1.3, Bmax 69 ± 22 finol / mg protein .
Indicating a very dense serotonin2 receptor population in the human umbilical
artery but lower affinity o f ketanserin for the receptors.
The specific binding o f the radioligand was also reversible and could be
displaced by increasing concentrations o f mianserin, serotonin and tyramine.
Norepinephrine was not able to displace the radioligand even at 10 pM
concentrations. Consistent with this result, Jazayeri et al. (1989) were unable to
displace 3H-serotonin with adrenergic agents in rat aortic smooth muscle cells.
Paradoxical to the observations o f the findings in the contractile studies, where
tissues were sensitive to ketanserin attenuation o f cocaine potentiated
norepinephrine contraction, norepinephrine was unable to displace 3H-ketanserin
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in the membrane binding studies. In the contractile studies, ketanserin with
cocaine was unable to antagonize the concentration-effect curve for
norepinephrine alone, consistent with the inability o f norepinephrine to displace
3H-ketanserin.
The concentration-dependent displacement o f 3H-ketanserin by tyramine is
a novel finding. While tyramine is reported to produce direct vasoconstrictive
effects in the umbilical artery (Gulati and Kelkar 1970) a receptor type for this
effect has never been described. Tyramine concentration-displacement curves fit
best to the two-site competition model indicating that tyramine binds at two
serotonin2 subtypes with very low affinity. In the contractile studies, tyramine
produced vasoconstriction at a concentration o f about 10-100 p M , and the KD
calculated for tyramine at the second site 36.2 pM is within this concentration.
This provides good evidence that tyramine is producing its contractile effects
through this receptor site, a serotonin2 subtype .
Serotonin concentration-displacement curves also fit best to the two-site
competition model indicating that serotonin binds at two serotonin2 receptor
subtypes. The KDvalues for serotonin in this tssue (KD2.8 and 2700 nM) were
higher than those for serotonin in cultured rat aortic smooth muscle (KD0.4 and 80
nM) indicating lower affinity o f serotonin for serotonin2 receptors in human
umbilical arteries. Based on the contractile responses to serotonin in the present
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study, the functional site for serotonin has a KDo f 2.8 nM in human umbilical
arteries.
Since norepinephrine (10 pM) did not displace 3H-ketanserin, the
vasoconstrictive effects o f norepinephrine are probably not produced through
serotonin2 receptors. This conflicts with the results of the ketanserin contractile
studies because cocaine potentiation o f norepinephrine was attenuated by
ketanserin. One explanation for this conflict might be that norepinphrine is
producing its effects through another serotonin receptor subtype for which
ketanserin has some affinity.
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CHAPTERS
SUMMARY AND CONCLUSIONS

1.

Tyramine produced a vasoconstrictive effect that was potentiated by
cocaine in the isolated human umbilical artery. Cocaine enhancement of
tyramine effects indicates that neuronal uptake o f tyramine is not necessary
for its sympathomimetic effect.

2.

Cocaine potentiation o f both serotonin and norepinephrine vasoconstrictive
responses indicates that the role of the umbilical artery in the
vasoconstrictive toxicity o f perinatal cocaine abuse is significant. The
mechanism whereby cocaine produces its potentiating effects remains
unclear.

3.

Norcocaine potentiation of norepinephrine responses provides evidence that
this cocaine metabolite may play a role in exacerbation o f the
vasoconstrictive complications attributed to perinatal cocaine abuse.
Calculated effects o f cocaine and its metabolites on norepinephrine induced
vasoconstriction revealed no significant differences. This indicates that in
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addition to cocaine and norcocaine, cocaethylene and benzoylecgonine may
contribute to umbilical artery toxicity.

4.

Cocaine metabolites norcocaine and cocaethylene did not produce
significant enhancement o f the serotonin contractile response. Maximum
responses to serotonin were decreased in the presence o f benzoylecgonine.
It is unclear why benzoylecgonine decreased the sensitivity of this tissue to
serotonin.

5.

Methoxamine did not produce vasoconstriction of the human umbilical
artery. This indicates that norepinephrine effects are unlikely to be
mediated through alpha, receptors in this tissue.

6.

Ketanserin abolished the potentiation o f serotonin and norepinephrine
responses by cocaine. Based on the findings o f these contractile studies,
cocaine potentiation o f serotonin and norepinephrine responses is mediated
through sertonin2 receptors.
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7.

Binding characteristics o f 3H-ketanserin reveal a very high KDfor ketanserin
in this tissue. Serotonin displaced ketanserin with very low affinity for
serotonin2 receptors. Since tyramine was able to displace 3H-ketanserin in
the membrane binding studies and its action is not dependent on neuronal
uptake, tyramine may produce this response through postsynaptic serotonin2
receptors. Norepinephrine did not displace 3H-ketanserin from the
membrane fraction in this assay.
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Effects o f Cocaine. Norcocaine. and Cocaethvlene on the Isolated Human
Umbilical Artery and Vein and the Influence o f Progesterone
Research to date indicates that infants delivered to cocaine or cocaine and ethanol
abusing mothers have displayed increased incidence o f neurological complications
as well as other congenital anomalies. Cocaine use during pregnancy has been
known to cause deleterious effects on placental function (decreased blood flow and
nutrient transport) and on the fetus (growth retardation, SIDS, and teratologic
effects) (Bingol et al. 1987), as well as on the pregnancy itself (spontaneous
abortion, abruptio placentae, and premature delivery) (Acker et al.1983). These
complications have generally been attributed to the sympathomimetic and
vasoconstrictive actions o f cocaine and its metabolites (Covert et al. 1994). The
primary pathophysiological action of cocaine and its other metabolites is related to
the onset o f hypertension and tachycardia. The etiology is directly related to
increases in circulating norepinephrine (NE), due to a block of the transport of NE
back into nerve terminals (Furchgott et al. 1963). This results in increased
stimulation o f alpha-1 and alpha-2 receptors by NE which causes vasoconstriction
(Bayorh et al. 1983).
Cocaine is extensively metabolized in the plasma and liver, and its
metabolites are cleared from the plasma more slowly than cocaine itself (Jatlow
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1987); this includes cocaethylene (Jatlow et al. 1991), a toxic metabolite formed
by the liver when cocaine and ethanol are used concomitantly (Boyer and Petersen,
1991). Cocaethylene is purported to be more toxic than cocaine and exhibits a
lower LD50 in mice (Hearn et al. 1991). In one experiment involving porcine fetal
cerebral arteries, cocaethylene was able to vasoconstrict these vessels more
efficaciously than cocaine. In the same study, norcocaine, (although a minor
metabolite o f cocaine), was shown to constrict these vessels as efficaciously as
cocaine itself (Kurth et al. 1993).
The toxicity o f cocaine and its metabolites is greater due to decreased
activity of cytochrome P450 enzymes during pregnancy and under the influence of
progesterone (Neale and Parks, 1973). Thus, progesterone increases enzymatic
demethylations thereby increasing plasma concentrations o f cocaine metabolites
which have longer half-lives than cocaine and increases vascular reactivity to
alpha-adrenergic receptor agonists. This suggests that pregnancy would increase
cocaine sensitivity by increasing the formation of norcocaine and decreasing
norcocaine metabolism. In one study, the cardiovascular toxicity to cocaine was
shown to be increased in the presence o f progesterone in nonpregnant ewes
(Plessinger and Woods et al. 1990).
Numerous studies which have been conducted in animal models and in
humans indicate that cocaine and its metabolites are rapidly transferred across the
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placenta. Cocaine and its metabolites are transferred almost as rapidly as
antipyrine, a substance which is used as a marker for placenta flow (Schenker et al.
1993). Although the placenta does contain considerable amounts o f smooth
endoplasmic reticulum and acetylcholinesterase as well as butyrylcholinesterase
activity has been confirmed in human placenta (Koshakji et al. 1974), there has
been no transplacental metabolism of cocaine observed to date.
The toxicology and teratology o f cocaine during pregnancy and in the
fetus can in part be attributed to vasoconstriction of the placenta (Mahalik et al.
1984). The vasoconstriction o f the placental vasculature has been postulated to
cause a decrease in uterine blood flow. Conversely, it has also been postulated that
it is the vasoconstriction o f the uterine vasculature initially which results in the
decrease in blood flow to the placenta (Morgan et al. 1991). Conclusive data has
yet to be presented to describe the true nature o f this relationship. This decrease in
blood flow has been proven to be the result of NE mediated vasoconstriction. This
has been shown experimentally by incorporating tropacocaine, an agent which
does not inhibit the reuptake of NE into the nerve terminal. In cocaine-exposed
animals, there was a decrease in the amount of radio-labelled sodium transferred to
the embryos. However, in the tropacocaine-exposed animals the transfer of the
isotope was not reduced significantly (Mahalik et al. 1980). In response to
intravenous cocaine administered to the uterine vasculature o f the pregnant ewe
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(Woods et al. 1987 and Moore et al. 1986), and to the pregnant nonhuman primate
(Morgan et al. 1991), a dose-dependent reduction o f uterine blood flow has been
observed. This results in increased blood pressure and restricts the transfer o f
essential nutrients and oxygen across the placenta.
There have been few studies conducted which attempt to delineate the
contribution of umbilical vasculature constriction to the fetal pathogenicity
observed in human epidemiological data and in the animal model as a result o f the
administration o f cocaine and its metabolites. Zhang and Dyer (1991) were able to
produce dose-dependent contractions o f the umbilical vein with NE, but did not
observe this effect in the umbilical artery. They also observed that neither the
EC50 nor the maximal contraction o f the umbilical vein to NE were affected by
cocaine, in contrast, tissue responsiveness in the vein to serotonin was potentiated
8.9 fold by cocaine. Serotonin (5-HT) seems to illicit stronger vasoconstrictive
responsiveness than epinephrine (EPI) or NE (even at large concentrations) in
umbilical arteries (Yoshikawa and Chiba, 1991). Thus it becomes very significant
to investigate the effects o f cocaine and its metabolites on this type of vasculature
in the presence o f 5-HT, NE, EPI, and dopamine (DA).
Unlike cocaine which acts at both dopaminergic and serotoninergic
reuptake sites (Ritz et al. 1990), cocaethylene acts preferentially to block reuptake
at dopaminergic nerve terminals (Woodward et al. 1991). Therefore, the first
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objective o f this study will be to evaluate the invovlement o f cocaine,
cocaethylene, and norcocaine in potentiating the vasoconstrictive responses o f the
isolated umbilical artery and vein to NE, 5-HT, EPI, and DA. Another point of
interest arises when it is considered that ethanol, a vasodilator, must be circulating
in order for the formation o f the toxic metabolite cocaethylene. The effect of this
compound on the vasoconstrictive effects o f cocaine and its metabolites will also
be evaluated in this model. Also, since it has been observed that the presence o f
progesterone increases the cardiovascular toxicity of cocaine, this effect will be
evaluated in this model along with the toxic metabolites, norcocaine, and
cocaethylene. If this toxicity is observed in this model, studies will then be
conducted using Mifepristone (RU486), a progesterone antagonist, to determine if
this effect can be blocked.
Materials and Methods
In order to determine the effect o f cocaine, norcocaine (NC), and
cocaethylene (CE) on the contractile activity o f isolated human umbilical arteries
and veins, umbilical artery and vein rings will be prepared for isometric tension
recording and exposed to pharmacologically relevant concentrations of these
agents by the method o f Saade, et al.1995. Briefly, umbilical cords will be
collected after vaginal or cesarean delivery and immediately placed in cold Krebsbicarbonate solution. Arteries and veins will be dissected and cut into rings about
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4 mm in length. The rings will be mounted in organ baths containing Krebsbicarbonate solution at 37°C on stirrups which will be calibrated for isometric
tension. A gas mixture o f 95% oxygen and 5% carbon dioxide will be used to
maintain tissue viability. Vascular ring tension will be equilibrated to about 2
grams or optimal tension depending on the responsiveness o f the tissues. The
rings will be contracted with KC1 to confirm tissue viability and responsiveness.
The contractile response o f each ring to the specific neurotransmitter, either NE, 5HT, EPI, or DA will be used as the reference to then be calculated as a percentage
o f its reference contraction. Each tissue will serve as its own control for
comparison of cocaine, NC and CE effects. A minimum of four and a maximum of
eight replicates will be done o f each dose response curve pending response
variation for statistical significance.
Experimental Protocol
In order to address all o f the aforementioned aims, this project will be
divided into four parts. The first experiment will be conducted to determine the
concentration o f Cocaine, NC or CE at which the dose response curves (10_7M 10'5M) to the neurotransmitters NE, EPI, DA, and 5-HT produces the greatest shift
in the EC50 to potentiate the response to these neurotransmitters. Tissues will be
exposed to concentrations o f metabolites beginning at 10"7M for at least 45
minutes prior to administration o f the neurotransmitters.
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In order to answer the question o f possible attenuation o f the
vasoconstrictive response o f the tissue to Cocaine, NC and CE by ETOH, the
second experiment will be performed to construct a dose response curve to ethanol
(25, 50, 100, 200 and 300 mg/dL) in the presence or absence o f each o f these
drugs. The attenuation of the contractile response produced by ETOH will be
expressed as a percentage o f the maximal contraction observed from each
compound. These dose response curves will be constructed in the presence o f
those doses of either cocaine, NC or CE which produced the greatest shift o f the
EC50 in the dose response curve for each o f the neurotransmitters.
The next set o f experiments will be conducted to determine what effect
exogenously applied progesterone will have on cocaine, NC or CE induced
vasoconstriction. A dose response curve will be constructed for progesterone at
concentrations which are characteristic o f the luteal phase o f the menstrual cycle
(mean 43 nmol/L, range 6-79.5 nmol/L) and the three trimesters o f pregnancy: 713 weeks (mean 86 nmol/L, range 32.6-139.9 nmol/L), 14-37 weeks (mean 162
nmol/L, range 62.0-262.4 nmol/L), and 30-42 weeks (mean 467 nmol/L, range
206.7-728.2 nmol/L). This dose reponse curve will then be reconstructed in the
presence o f cocaine, NC and CE and 50% dilatory dose of ETOH for comparison
to the initial curve to determine if there is an interactive response o f progesterone
with these substances.
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Mifepristone (RU486) will be used in the final set of experiments to
determine if the enhanced vasoconstriction o f cocaine, NC and CE mediated by
progesterone can be blocked, if this effect is observed for progesterone. The
isolated arteries and veins will be pretreated with single competitively antagonistic
doses o f Mifepristone, then exposed to the aforementioned doses o f progesterone
alone and with addition o f 50% contractile doses o f cocaine, NC and CE. The
attenuation o f Mifepristone will be calculated as a percentage o f the maximum
tension produced in the presence o f progesterone for each compound.
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INFORMATION ABOUT: Effects of Cocaine, Norcocaine, and Cocaethylene on the
Isolated Umbilical Artery and Vein, and the Influence of Progesterone.
INVESTIGATORS: Kenneth E. Ferslew, PhD., Tessa L. Long, Peter J. Rice, PhD., and
Frederick R. Jelovsek, M.D.
CONSENT FORM
I understand that the purpose of this research project is to leam more about how
the body works and changes in response in pregnancy, medicines, and disease. After
delivery and detachment of the umbilical cord, we will examine the response of nerve
chemicals in the blood vessels to drugs of abuse. Also, we will try to determine if
hormones present during pregnancy will enhance the effects of these drugs on the blood
vessels.
I understand that my involvement in the study will be my consent for the
umbilical cord (after delivery) to be used in this project. The umbilical cord which would
normally be discarded after birth will instead be taken to the laboratory for
experimentation.
Approximately 50 umbilical cords will be used in this study at the Johnson City
Medical Center Hospital and the E.T.S.U. Department of Pharmacology, Quillen College
of Medicine.
All medical procedures are required as part of my treatment. I understand that
there are no additional risks associated with this study.
I understand that there are no benefits to me as a participant in this study.
The purpose of the study is to leam more about how the body functions normally
and under the influence of drugs. My participation may benefit others in the future.
There is no additional cost for participating in this study.
I understand that my participation is voluntary. I realize that refusal to participate
will in no way jeopardize benefits or treatments to which I am otherwise entitled. I am
free to withdraw at any time without penalty or loss of benefits to which I am entitled. I
understand that I may withdraw by notifying Tessa L. Long at 439-6208 or Kenneth E.
Ferslew, PhD. at 439-6274. If I have any questions about the study I may contact either of
these people as well.
Any questions about my rights as a research subject can be addressed to the ETSU
Institutional Review Board (423/439-6134). East Tennessee State University does not
provide compensation for medical treatment other than emergency first aid for any injury
which may occur as a result of your participation as a subject in this experiment, claims
arising against ETSU or any of its agents or employees may be submitted to the
Tennessee Claims Commission for disposition to the extent allowable as provided under
TC Section 9-8-307. Additional information concerning this may be obtained from the
Chairman of the Institutional Review Board (IRB), 439-6134.
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INFORMATION ABOUT: Effects of Cocaine, Norcocaine, and Cocaethylene on the
Isolated Umbilical Artery and Vein, and the Influence of Progesterone.
INVESTIGATORS: Kenneth E. Ferslew, PhD., Tessa L. Long, Peter J. Rice, PhD., and
Frederick R. Jelovsek, M.D.
I understand that a copy of the results of this experiment will be deposited on file
in the Department of Toxicology, West Side of Memorial Center W269 on the ETSU
campus for a period of at least 10 years after completion of the research project I
understand that results of this study may be published and/or presented at meetings. I
understand that study records are accessible to: ETSU IRB, Department of Health and
Human Services, and coinvestigators. I also understand that my medical records will be
maintained in strictest confidence according to current legal requirements, and will not be
revealed unless required by law, except as noted above.
By signing below, I certify that I have read or had this document read to me and I
have been given a copy. I have been given the opportunity to ask questions and to
discuss my participation with the investigator. I freely and voluntarily choose to
participate in this research experiment.

Patient’s Signature

Date

Witness’ Signature

Date

Investigator’s Signature

Date
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Modified Krebs-Henseleit Buffer
Reagents
Stock A (IPX Concentrate)
Molecular Wt.

Mass (g)

Sodium Cholride

58.44

132.00

Potassium Chloride

74.56

7.083

Calcium Chloride* 2H20

147.07

7.412

Magnesium Sulfate *7H20

246.48

5.866

Dextrose

180.16

20.00

Dissolve in Deionized Water

2000ml

Stock B (1QX Concentrate!
Potassium Hyd. Phosphate

136.09

3.212

Sodium Bicarbonate

84.01

42.00

Dissolve in Deionized Water

2000ml
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Procedure
1.

For 2 liters o f buffer, add 200 ml of stock A and B to a volumetric flask and
bring up to volume with deionized water.

2.

Addition o f deionized water (about 500 ml) between the mixing of stock
aliquots prevents precipitation of calcium salts.

3.

The buffer is aerated with 95%02/ 5% C 0 2 for about 30 min before use.
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Modified Krebs-Henseleit Buffer 65mM PotassiumReplacing Sodium
Reagents
Stock A (IPX Concentrated
Molecular Wt.

Mass (g)

Sodium Chloride

58.44

15.741

Potassium Chloride

74.56

23.792

Calcium Chloride*2H20

147.07

1.853

Magnesium Sulfate«2H20

246.48

1.466

Dextrose

180.16

5.00

Dissolve in Deionized water

500ml

Stock B (10X Concentrate)
Potassium Hyd. Phosphate

136.09

3.212

Sodium Bicarbonate

84.01

42.00

Dissolve in Deionized water

2000ml
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Procedure
1.

For 1 liter 65 mM K+ buffer, add 100 ml of stock A and B and bring up to
volume with deionozed water.

2.

Addition o f deionized water ( about 500 ml) between addition o f stock
aliquots prevents the precipitation o f calcium salts.

3.

The buffer is aerated with 95% 02/ 5% C 0 2 for about 30 min before use.
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Bradford Protein Assay
Principle
The Bradford method is based on the shift in absorption maximum (from
465 to 595 nm) which occurs when protein binds to the dye Coomassie Brilliant
Blue G-250. This protein assay is very reproducible and rapid; there is little
interference from cations such as sodium or potassium nor from carbohydrates.
Interfering color can be produced by large amounts o f detergents.
Materials
Microtiter plates
Equipment
Spectra Max 340 Microplate Spectrophotometer
(Molecular Devices, Sunnyvale, CA)
Reagent
Bio-Rad Protein Assay Dye Reagent Concentrate
Bovine Serum Albumin (BSA) (1 mg/ml)
Procedure
1.

Prepare lOOpl BSA standards containing 0, 0.1, 0.25, 0.5, 1.0,2.5, 5.0,
10.0,25.0, 50.0, 100.0 pg. Use lOOpl sample o f unknown concentration
(0.25-10 pg) protein.

2.

Add 150 pi of diluted (1 part Reagent plus 2 parts water) Bio-Rad Dye and
mix well. The reaction is complete within 2 min and is stable for 1 hour.

3.

Read absorbance at 595 nm against a control with zero protein.

Calculations
A standard curve is constructed using bovine serum albumin and used to
convert absorbance at 595 nm to an equivalent protein concentration.
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Figure 21. Standard curve for Bradford protein assay. Data are
represented by the mean of 4 replicates.
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Education:
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High School Diploma (1987)
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